CAROLYN BERTOZZI, STANFORD UNIVERSITY
The Bertozzi Group studies cell surface interactions that contribute to human health and disease with specific projects in the areas of cancer, inflammation and bacterial infection.
In this talk, Dr. Kamm will present some recent advances in modeling the successive stages of metastatic cancer, especially in the context of immunotherapies and organ-specific models of metastasis.
ALEXANDER DUNN, DEPARTMENT OF CHEMICAL ENGINEERING
Attend Dr. Dunn's pre-seminar presentation to learn more about Dr. Roger Kamm's seminar, "In Vitro Vascularized Models for Metastatic Cancer", to be held Thursday, May 19th.
WOLFGANG BAUMEISTER, MAX PLANCK INSTITUTE
Projects in Dr. Baumeister's group include using Cryo-Electron Tomography, exploring phase contrast methods, understanding the 26S proteasome, studying the structural mechanisms of neuodegenerative disease, studying the structural mechanisms of visual proteomics, studying tripeptidyl peptidase II, studying the 70S ribosome, examining membrane and cell wall proteins, and studying synaptic complexes.
“Mice are not little people” – a refrain becoming louder as the strengths and weaknesses of animal models of human disease become more apparent. At the same time, three emerging approaches are headed toward integration: powerful systems biology analysis of cell-cell and intracellular signaling networks in patient-derived samples; 3D tissue engineered models of human organ systems, often made from stem cells; and micro-fluidic and meso-fluidic devices that enable living systems to be sustained, perturbed and analyzed for weeks in culture. This talk will highlight the integration of these rapidly moving fields to understand difficult clinical problems, with an emphasis on translating academic discoveries into practical, widespread use.
OVIJIT CHAUDHURI, DEPARTMENT OF MECHANICAL ENGINEERING
Attend Dr. Chaudhuri's pre-seminar presentation to learn more about Dr. Linda Griffith's seminar, "Move Over, Mice: How Integration of Systems Biology with Organs-on-Chips May Humanize Therapeutic Development", to be held Thursday, April 28th.
LINGCHONG YOU, DUKE UNIVERSITY
The You lab's research is at the nexus of biology, engineering, and medicine. They combine mathematical modeling and experiments to analyze dynamics of cell signaling processes, including cell cycle regulation, bacterial response to antibiotics, and cell-cell communication.
MARK BRYNILDSEN, PRINCETON UNIVERSITY
The Brynildsen research group uses both computational and experimental techniques in systems biology, synthetic biology, and metabolic engineering to understand and address threats to human health.
CHANDRA TUCKER, UNIVERSITY OF COLORADO AT DENVER
Dr. Tucker will discuss recent work using CRY2 to regulate protein-protein interactions, alter protein localization, induce enzyme activity, or disrupt protein function using light.
Stanford Bio-X is now accepting Letters of Intent for the 8th Round of the Stanford Bio-X IIP Seed Grants!
LOIs must be received by April 6, 2016 at 5:00 pm PST.
